| JXHL2100089 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2021-03-20 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2022-01-27 | view |
| JXHS2000154 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-10-14 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-07-30 | view |
| JXHS2000153 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-10-14 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-07-30 | view |
| JXHS2000156 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-10-14 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-07-30 | view |
| JXHS2000155 | 吡仑帕奈片 | Perampanel | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2020-10-14 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-07-30 | view |
| JXHL2000300 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2020-11-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-05-09 | view |
| JXHB2000042 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Supplementary Application | 2020-10-29 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-05-09 | view |
| JXHB2100028 | E7090片 | tasurgratinib | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-03-23 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-22 | view |
| JXHL2100088 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2021-03-20 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-19 | view |
| JXHL2100094 | Dotinurad片 | dotinurad | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-03-20 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-19 | view |
| JXHL2100095 | Dotinurad片 | dotinurad | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2021-03-20 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-19 | view |
| JYHB2100198 | 盐酸司来吉兰片 | selegiline hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2021-03-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-12 | view |
| JXHL2100086 | 吡仑帕奈口服混悬液 | Perampanel | Suspension | Chemical Drugs(5.1) | Import Drug Application | 2021-03-12 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-03-12 | view |
| JYHB2100097 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2021-01-27 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-01-26 | view |
| JYHB2100098 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(5.1) | Supplementary Application | 2021-01-27 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2021-01-26 | view |
| JYHB2001886 | 米格列奈钙片 | Mitiglinide calcium | Tablet | Chemical Drugs | Supplementary Application | 2020-09-27 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-01-04 | view |
| JYHB2001885 | 米格列奈钙片 | Mitiglinide calcium | Tablet | Chemical Drugs | Supplementary Application | 2020-09-27 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-01-04 | view |
| JYHB2001884 | 米格列奈钙片 | Mitiglinide calcium | Tablet | Chemical Drugs | Supplementary Application | 2020-09-27 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-01-04 | view |
| JYHB2001887 | 米格列奈钙片 | Mitiglinide calcium | Tablet | Chemical Drugs | Supplementary Application | 2020-09-27 | 卫材（中国）药业有限公司 | Eisai China Inc | Certificate Issued | 2021-01-04 | view |
| JXHL2000351 | 甲磺酸仑伐替尼胶囊 | Lenvatinib mesylate | Capsule | Chemical Drugs(2.4) | Import Drug Application | 2020-12-28 | 卫材（中国）药业有限公司 | Eisai China Inc | In Review | 2020-12-26 | view |
